Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus

This study has been completed.
Sponsor:
Information provided by:
Haydarpasa Numune State Hospital
ClinicalTrials.gov Identifier:
NCT00463502
First received: April 19, 2007
Last updated: NA
Last verified: March 2007
History: No changes posted
  Purpose

Aim: To investigate the effects of metformin treatment on thyroid hormone metabolism in euthyroid patients with type 2 diabetes mellitus.


Condition Intervention Phase
Diabetes Mellitus, Type 2
Drug: Metformin
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label

Resource links provided by NLM:


Further study details as provided by Haydarpasa Numune State Hospital:

  Eligibility

Ages Eligible for Study:   35 Years to 78 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • The patients included in this study were the ones who were newly diagnosed with type 2 diabetes mellitus

Exclusion Criteria:

  • Presence of thyroid disorders, positive thyroid autoantibodies and usage of medications affecting thyroid hormones such as amiodarone, lithium were accepted as exclusion criterions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00463502

Sponsors and Collaborators
Haydarpasa Numune State Hospital
Investigators
Principal Investigator: Ali Ozdemir Unaffiliation
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00463502     History of Changes
Other Study ID Numbers: 07-013
Study First Received: April 19, 2007
Last Updated: April 19, 2007
Health Authority: Turkey: Ministry of Health

Keywords provided by Haydarpasa Numune State Hospital:
The purpose of study was investigated the effect of
metformin on thyroid hormone metabolism in euthyroid patients
with type 2 DM. The results revealed significant decreases
in TSH and fT4

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Metformin
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on November 20, 2014